International organization UNITAID announced in Geneva on Friday that an agreement has been signed to halve the prices of Kovid-19 antigenic tests rapidly for the benefit of low and middle-income countries.
The agreement between UniteAid and the Foundation for Innovative Diagnostics “will increase the capacity of companies that manufacture these rapid antigen detection tests and meet nearly half of the projected needs of low- and middle-income countries. It ranges from $ 5 to $ 2.5. , “Hervé Verhoosel, spokesperson for Unitaid, an international organization organized by the WHO, indicated during a press conference. United Nations in Geneva.”
According to Verohosal, some 264 million trials could be produced within 12 months of the agreement.
Testing to detect Kovid-19 infections is an important tool for better treatment, but better epidemics to be able to isolate them early to detect foci of infection and thus prevent further spread of the virus Also to counter.
This is especially true for low and middle-income countries, where health workers are often denied tests due to the fragility of the health system and dependence on supplies from abroad, Sh. Varahosal.
Less efficient than PCR tests, antigenic tests do not require laboratory analysis and have the advantage of producing results in about fifteen minutes.
Internet geek. Wannabe bacon enthusiast. Web trailblazer. Music maven. Entrepreneur. Pop culture fan.